Cambrex advances $120M API plant expansion in Iowa and R&D buildout in Italy

Cambrex completed initial engineering studies for a new large-scale API manufacturing plant in Charles City, Iowa, as part of a $120 million U.S. expansion, with groundbreaking scheduled for late 2026. In Milan, Italy, a $30 million expansion adding analytical development and process R&D capabilities is underway, expected to complete in H2 2027.

“Cambrex, a contract development and manufacturing organization (CDMO) headquartered in East Rutherford, New Jersey, has completed initial engineering studies for a new large-scale active pharmaceutical ingredient (API) manufacturing plant in Charles City, Iowa.”megaproject.com

• 1 source
• megaproject.comCambrex advances $120M API plant expansion in Iowa, R&D buildout in ItalyApr 1, 2026

Summarized from public sources; check the original articles before acting on it.